Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diseases of the Thyroid
  Free Subscription

Articles published in
Endocr J
    September 2025
  1. NAKASHIMA Y, Horie I, Arimori H, Ueda M, et al
    Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer.
    Endocr J. 2025 Sep 4. doi: 10.1507/endocrj.EJ25-0251.
    >> Share

    July 2025
  2. SAILAUBEKOVA Y, Matsuda K, Akazawa Y, Kurohama H, et al
    Altered expression of autophagy-related molecules and beta-catenin in different subtypes of thyroid cancer: co-localization in intranuclear cytoplasmic inclusions.
    Endocr J. 2025 Jul 17. doi: 10.1507/endocrj.EJ25-0181.
    >> Share

  3. SATO M, Kubota R, Uchino S, Morita T, et al
    p.M918W, a novel RET germline variant: a case report and literature review of the possible association of multiple endocrine neoplasia type 2B and Charcot-Marie-Tooth disease.
    Endocr J. 2025;72:839-845.
    >> Share

    June 2025
  4. NAGAYAMA Y, Tajiri J, Murakami T, Watanabe N, et al
    A questionnaire survey of thyroid specialists in Japan on the use of thyroid hormones in hypothyroid and euthyroid patients.
    Endocr J. 2025 Jun 10. doi: 10.1507/endocrj.EJ25-0106.
    >> Share

  5. AMANO I, Ninomiya A, Koibuchi N
    Neurological consequences of adult-onset hypothyroidism.
    Endocr J. 2025 Jun 4. doi: 10.1507/endocrj.EJ25-0163.
    >> Share

  6. MURAKAMI T, Higaki N, Nishijima Y, Tani J, et al
    Goiter index: an easily available ultrasonographic index for thyroid volume in autoimmune thyroid diseases.
    Endocr J. 2025 Jun 3. doi: 10.1507/endocrj.EJ25-0070.
    >> Share

    May 2025
  7. AMANO I, Ninomiya A, Yajima H, Suda-Yajima M, et al
    Effects of excessive iodine intake during the perinatal period on thyroid function and higher brain functions in mouse offspring.
    Endocr J. 2025 May 28. doi: 10.1507/endocrj.EJ24-0723.
    >> Share

  8. HOSODA A, Arata N, Umehara N, Sato S, et al
    Prediction of fetal Graves' disease among pregnant women with Graves' disease who have undergone thyroidectomy or radioactive iodine therapy: A retrospective observational study.
    Endocr J. 2025 May 17. doi: 10.1507/endocrj.EJ24-0434.
    >> Share

    April 2025
  9. NOH JY, Watanabe N, Ito K, Tsuiki M, et al
    Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70(TM) in Japanese Graves' disease patients: results of a phase 1 trial.
    Endocr J. 2025 Apr 29. doi: 10.1507/endocrj.EJ25-0043.
    >> Share

  10. HONG-QUN W, Ya-Qi M, Ying L, Huai-Yin S, et al
    Clinicopathological features of follicular thyroid carcinoma coexisting with papillary thyroid carcinoma.
    Endocr J. 2025 Apr 24. doi: 10.1507/endocrj.EJ24-0523.
    >> Share

    March 2025
  11. NAGAYAMA Y, Tachibana S, Fukuda T, Katsuyama K, et al
    Early postoperative levothyroxine initiation after total thyroidectomy for Graves' disease.
    Endocr J. 2025 Mar 27. doi: 10.1507/endocrj.EJ25-0009.
    >> Share

  12. HOSHIYAMA A, Hayashi A, Taguchi T, Ohata Y, et al
    Disseminated intravascular coagulation as a frequent and critical complication of thyroid storm: a single-center retrospective survey.
    Endocr J. 2025 Mar 22. doi: 10.1507/endocrj.EJ24-0542.
    >> Share

  13. ITO Y, Yamamoto M, Kihara M, Onoda N, et al
    Establishment of novel prognostic groups for papillary thyroid carcinoma using a modified risk classification based on tumor extension in the guidelines of the Japan Association of Endocrine Surgery.
    Endocr J. 2025 Mar 8. doi: 10.1507/endocrj.EJ24-0610.
    >> Share

  14. SUGITANI I, Kiyota N, Ito Y, Onoda N, et al
    The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery.
    Endocr J. 2025 Mar 8. doi: 10.1507/endocrj.EJ24-0644.
    >> Share

    February 2025
  15. NISHIJIMA Y, Murakami T, Higaki N, Tani J, et al
    The prognosis of severe subclinical hyperthyroidism with TSH below 0.1 muU/mL due to Graves' disease in the Japanese population.
    Endocr J. 2025 Feb 26. doi: 10.1507/endocrj.EJ24-0424.
    >> Share

  16. TAKIZAWA H, Uchida T, Suzuki N, Onose H, et al
    Influence of therapeutic inorganic iodine on long-term prognosis of Graves' disease: a multicenter prospective observational study.
    Endocr J. 2025 Feb 22. doi: 10.1507/endocrj.EJ24-0575.
    >> Share

  17. ITO Y, Sakumoto J, Hirabayashi H, Haruna S, et al
    Assessing the potential of high-mobility group AT-hook 2 immunohistochemical staining as a prognostic marker of metastatic recurrence in follicular thyroid cancer: a retrospective cohort study.
    Endocr J. 2025 Feb 19. doi: 10.1507/endocrj.EJ24-0557.
    >> Share

  18. HATAYA Y, Fujishima Y, Fujimoto K, Iwakura T, et al
    Association between serum thyroglobulin levels and glycemic control in patients with thyroid cancer after radioiodine therapy.
    Endocr J. 2025 Feb 1. doi: 10.1507/endocrj.EJ24-0417.
    >> Share

  19. SHIBATA Y, Oiwa A, Tanaka H, Kubota S, et al
    Characteristics of patients with Graves' disease who developed drug resistance and required surgery.
    Endocr J. 2025 Feb 1. doi: 10.1507/endocrj.EJ24-0494.
    >> Share

    January 2025
  20. YOSHIHARA A, Noh JY, Inoue K, Koshibu M, et al
    Long-term outcomes after a radioactive iodine treatment for a single autonomous functioning thyroid nodule in Japan.
    Endocr J. 2025 Jan 23. doi: 10.1507/endocrj.EJ24-0578.
    >> Share

    December 2024
  21. NGUYEN VPT, Kurohama H, Akazawa Y, Nguyen TNA, et al
    Clinicopathological and molecular characteristics of papillary thyroid carcinoma in adolescent and young adult patients.
    Endocr J. 2024 Dec 3. doi: 10.1507/endocrj.EJ24-0504.
    >> Share

    October 2024
  22. ITO Y, Kawakami M, Hirokawa M, Yamamoto M, et al
    Management of thyroid tumors diagnosed cytologically as follicular neoplasms in a high-volume center: utility of a scoring system using serum thyroglobulin level, tumor size, ultrasound testing, and cytological diagnosis.
    Endocr J. 2024 Oct 29. doi: 10.1507/endocrj.EJ24-0364.
    >> Share

  23. ITO M, Deguchi-Horiuchi H, Takahashi S, Hisakado M, et al
    Current status of the thyroid hormone measurement items in patients receiving levothyroxine monotherapy by the management based on the thyroid tissue volume.
    Endocr J. 2024 Oct 23. doi: 10.1507/endocrj.EJ24-0259.
    >> Share

  24. SUZUKI N, Yoshimura Noh J, Kozaki A, Watanabe N, et al
    Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves' disease.
    Endocr J. 2024 Oct 23. doi: 10.1507/endocrj.EJ24-0401.
    >> Share

  25. INAISHI T, Takeuchi D, Ichikawa T, Inaguma G, et al
    Impact of periodic neck ultrasonography on locoregional disease control in surveillance after total thyroidectomy for patients with low- and intermediate-risk papillary thyroid carcinoma: a propensity score-matched study.
    Endocr J. 2024 Oct 1. doi: 10.1507/endocrj.EJ24-0194.
    >> Share

    September 2024
  26. MIZUOCHI K, Hiromatsu Y, Nakamura Y, Sonezaki A, et al
    Transition from hypothyroidism to Graves' disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature.
    Endocr J. 2024 Sep 25. doi: 10.1507/endocrj.EJ24-0347.
    >> Share

  27. TAZAKI R, Kobashi Y, Nakahata N, Asano M, et al
    Potential implications of thyroid autoantibodies in children, adolescents, and young adults with thyroid nodules in Japan: The Fukushima Health Management Survey.
    Endocr J. 2024 Sep 20. doi: 10.1507/endocrj.EJ24-0293.
    >> Share

  28. WATANABE N
    A narrative review of long-term inorganic iodine monotherapy for Graves' disease with a historical relationship between iodine and thyroid.
    Endocr J. 2024 Sep 5. doi: 10.1507/endocrj.EJ24-0186.
    >> Share

  29. YOON Y, Park HY, Chae MK, Jang SY, et al
    Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves' orbitopathy.
    Endocr J. 2024;71:851-861.
    >> Share

    June 2024
  30. MANAKA K, Sato J, Hikima Y, Horikoshi H, et al
    Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study.
    Endocr J. 2024 Jun 5. doi: 10.1507/endocrj.EJ23-0699.
    >> Share

    May 2024
  31. YOSHIMURA NOH J, Inoue K, Suzuki N, Yoshihara A, et al
    Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.
    Endocr J. 2024 May 3. doi: 10.1507/endocrj.EJ24-0135.
    >> Share

    April 2024
  32. YAMAGAMI A, Iwama S, Kobayashi T, Zhou X, et al
    Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade.
    Endocr J. 2024 Apr 11. doi: 10.1507/endocrj.EJ23-0480.
    >> Share

  33. MURAKAMI T, Higaki N, Nishijima Y, Tani J, et al
    An easy approach to ultrasonographic volumetry of the thyroid.
    Endocr J. 2024 Apr 11. doi: 10.1507/endocrj.EJ23-0606.
    >> Share

    March 2024
  34. SHIBATA N, Numakura C, Hamajima T, Miyako K, et al
    Clinical and molecular analyses of isolated central congenital hypothyroidism based on a survey conducted in Japan.
    Endocr J. 2024 Mar 8. doi: 10.1507/endocrj.EJ23-0391.
    >> Share

    February 2024
  35. NAKAHATA N, Asano M, Abe N, Ejiri H, et al
    Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.
    Endocr J. 2024 Feb 16. doi: 10.1507/endocrj.EJ23-0609.
    >> Share

    January 2024
  36. FUKUDA N, Toda K, Suto H, Oki R, et al
    Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
    Endocr J. 2024 Jan 31. doi: 10.1507/endocrj.EJ23-0378.
    >> Share

  37. DEGUCHI-HORIUCHI H, Ito M, Takahashi S, Kousaka K, et al
    Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies.
    Endocr J. 2024 Jan 31. doi: 10.1507/endocrj.EJ23-0497.
    >> Share

  38. OMI Y, Yanagida J, Yoshida Y, Horiuchi K, et al
    Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography?
    Endocr J. 2024 Jan 19. doi: 10.1507/endocrj.EJ23-0413.
    >> Share

    December 2023
  39. TODA S, Iwasaki H, Okubo Y, Hayashi H, et al
    The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
    Endocr J. 2023 Dec 1. doi: 10.1507/endocrj.EJ23-0342.
    >> Share

    November 2023
  40. KOBAYASHI T, Iwama S, Arima H
    Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events.
    Endocr J. 2023 Nov 7. doi: 10.1507/endocrj.EJ23-0524.
    >> Share

    October 2023
  41. MO C, Zhong L
    The effect of acromegaly on thyroid disease.
    Endocr J. 2023 Oct 25. doi: 10.1507/endocrj.EJ23-0356.
    >> Share

  42. ITO Y, Miyauchi A, Fujishima M, Yamamoto M, et al
    Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
    Endocr J. 2023 Oct 4. doi: 10.1507/endocrj.EJ23-0395.
    >> Share

    September 2023
  43. HAGA E, Inoue N, Iwatani Y, Arakawa Y, et al
    Intraindividual variation in histone acetylation and its impact on autoimmune thyroid diseases.
    Endocr J. 2023 Sep 30. doi: 10.1507/endocrj.EJ23-0204.
    >> Share

  44. KAWAMOTO T, Yasuda K, Ito Y, Zenda S, et al
    Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan.
    Endocr J. 2023 Sep 30. doi: 10.1507/endocrj.EJ23-0330.
    >> Share

  45. WATANABE N, Yoshimura Noh J, Kozaki A, Yoshimura R, et al
    Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal
    Endocr J. 2023 Sep 22. doi: 10.1507/endocrj.EJ23-0079.
    >> Share

  46. ARIMITSU H, Nishijima Y, Higaki N, Noguchi H, et al
    A case report of anaplastic thyroid carcinoma transformed from small papillary carcinoma successfully detected by ultrasonography in its early stage with review of literature.
    Endocr J. 2023 Sep 16. doi: 10.1507/endocrj.EJ23-0197.
    >> Share

  47. DEANDREA M, Piticchio T, Mormile A, Retta F, et al
    Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
    Endocr J. 2023 Sep 9. doi: 10.1507/endocrj.EJ23-0273.
    >> Share

    August 2023
  48. YAMAUCHI I, Hakata T, Sugawa T, Kosugi D, et al
    Prediction-based prompt levothyroxine replacement to prevent a hypothyroid state after immune-related adverse events involving the thyroid gland.
    Endocr J. 2023 Aug 11. doi: 10.1507/endocrj.EJ23-0262.
    >> Share

  49. MATSUSE M, Mitsutake N
    TERT promoter mutations in thyroid cancer.
    Endocr J. 2023 Aug 1. doi: 10.1507/endocrj.EJ23-0136.
    >> Share

    June 2023
  50. FUJISHIMA M, Miyauchi A, Ito Y, Sasaki T, et al
    Outcomes of immediate surgery for low-risk papillary thyroid microcarcinoma in patients with or without risky features at surgery.
    Endocr J. 2023 Jun 28. doi: 10.1507/endocrj.EJ23-0107.
    >> Share

  51. SHIMMARU K, Inami M, Hamaoka A, Fujiwara N, et al
    Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
    Endocr J. 2023 Jun 17. doi: 10.1507/endocrj.EJ23-0062.
    >> Share

    May 2023
  52. TERASHIMA R, Tani T, Sakakibara K, Kurusu S, et al
    Thyrotropin-releasing hormone stimulates NR4A3 expression in the pituitary thyrotrophs of proestrus rats.
    Endocr J. 2023 May 19. doi: 10.1507/endocrj.EJ23-0080.
    >> Share

    April 2023
  53. SHI W, Song D, Chen D, Duan W, et al
    The association of thyroid parameters with markers of chronic kidney disease in euthyroid patients with type 2 diabetes.
    Endocr J. 2023 Apr 21. doi: 10.1507/endocrj.EJ22-0643.
    >> Share

    March 2023
  54. NAGATA K, Hayashi K, Kumata K, Satoh Y, et al
    Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
    Endocr J. 2023 Mar 10. doi: 10.1507/endocrj.EJ22-0609.
    >> Share

    February 2023
  55. MIKURA K, Yoshimura Noh J, Watanabe N, Aida A, et al
    Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
    Endocr J. 2023 Feb 25. doi: 10.1507/endocrj.EJ22-0505.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016